These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 143285)

  • 1. Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analog.
    Lien EL; Fenichel RL; Grant NH; Boxill GC; Greenwood J; Yardley JP
    Biochem Biophys Res Commun; 1977 Aug; 77(4):1317-25. PubMed ID: 143285
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analog.
    Lien EL; Fenichel RL; Grant NH; Boxill GC; Greenwood J; Yardley JP
    Metabolism; 1978 Sep; 27(9 Suppl 1):1403-6. PubMed ID: 683008
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic effects of long-term somatostatin infusion in man.
    Gerich JE
    Metabolism; 1976 Nov; 25(11 Suppl 1):1505-7. PubMed ID: 988466
    [No Abstract]   [Full Text] [Related]  

  • 4. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus.
    Ward FR; Leblanc H; Yen SS
    J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.
    Trovati M; Massara F; Camanni F; Molinatti GM; Lorenzati R; Pagano GF
    J Endocrinol Invest; 1980; 3(2):189-92. PubMed ID: 6104680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of somatostatin in the study of carbohydrate homeostasis in man: physiologic, pathologic, and therapeutic considerations.
    Gerich JE
    Adv Exp Med Biol; 1977; 87():299-318. PubMed ID: 143198
    [No Abstract]   [Full Text] [Related]  

  • 7. Somatostatin in maturity-onset diabetes.
    Christensen SE; Hansen AP; Lundbaek K
    Diabetes; 1978 Oct; 27(10):1013-9. PubMed ID: 700257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged suppression of insulin release by a somatostatin analog.
    Lien EL; Garsky VM
    Endocrinology; 1978 Jul; 103(1):81-5. PubMed ID: 744088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
    Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM
    Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin (growth hormone-release inhibiting hormone).
    Gomez-Pan A; Hall R
    Clin Endocrinol Metab; 1977 Mar; 6(1):181-200. PubMed ID: 196795
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.
    Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Ala-2-D-Trp-8-D-Cys-14-somatostatin on the arginine induced release of insulin, GH and glucagon in normal men.
    Gonzalez-Barcena D; Mendoza F; Medina R; Coy DH; Murphy WA; Schally AV
    Endocr Res; 1984; 10(1):39-48. PubMed ID: 6146518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin-28 is longer acting and more selective than somatostatin-14 on pituitary and pancreatic hormone release.
    Tannenbaum GS; Ling N; Brazeau P
    Endocrinology; 1982 Jul; 111(1):101-7. PubMed ID: 6123428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
    Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
    Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
    [No Abstract]   [Full Text] [Related]  

  • 16. [Somatostatin--a hypothalamic factor inhibiting the secretion of growth hormone].
    Lankosz-Lauterbach J
    Pediatr Pol; 1977 Aug; 52(8):919-23. PubMed ID: 333364
    [No Abstract]   [Full Text] [Related]  

  • 17. Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabetics.
    Christensen SE; Hansen AP; Orskov H; Lundbaek K
    Metabolism; 1978 Sep; 27(9 Suppl 1):1427-31. PubMed ID: 683011
    [No Abstract]   [Full Text] [Related]  

  • 18. Antidiabetic action of somatostatin after oral glucose loading: due to suppression of glucagon and growth hormone or of intestinal carbohydrate absorption?
    Bratusch-Marrain P; Vierhapper H; Grubeck-Loebenstein B; Waldhäusl W; Nowotny P
    Horm Metab Res; 1981 Jun; 13(6):305-9. PubMed ID: 6114914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a nonreducible cyclic analog of somatostatin having only growth hormone release inhibiting activity.
    Garsky VM; Clark DE; Grant NH
    Biochem Biophys Res Commun; 1976 Dec; 73(4):911-6. PubMed ID: 15625860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of streptozotocin on insulin and glucagon responses of rat islets.
    Katsilambros N; Rahman YA; Hinz M; Fussgänger R; Schröder KE; Straub K; Pfeiffer EF
    Horm Metab Res; 1970 Sep; 2(5):268-70. PubMed ID: 4258677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.